USE OF EF-TS FOR TREATING SMOOTH MUSCLE CELL HYPERPLASIA

摘要

The invention concerns the use of the gene coding for EF-Ts of mammals for treating and diagnosing diseases involving smooth muscle cell hyperplasia, dedifferenciation of the smooth muscle cells and/or cell or cancerogenic transformation of the smooth muscle cells. The invention also concerns the use of a compound for inhibiting the expression or activity of EF-Ts, in particular of an antisense oligonucleotide or of an antibody for treating cardiovascular diseases and cancer.